Recombinant Renibacterium salmoninarum Transaldolase (tal)

Shipped with Ice Packs
In Stock

Description

Overview of Renibacterium salmoninarum and Its Protein Targets

R. salmoninarum, the causative agent of bacterial kidney disease (BKD), produces several immunologically and metabolically significant proteins. Key findings include:

  • p57 (msa gene product): A major secreted antigen with leucocyte-agglutinating activity, critical for immune evasion . Recombinant p57 fragments have been used to study epitope localization and immune responses .

  • Dihydrofolate Reductase (DHFR): Identified as a potential drug target via homology modeling and docking studies. Trimethoprim showed strong binding affinity (9.06 kcal/mol-9.06\ \text{kcal/mol}) to DHFR in computational analyses .

Transaldolase in Bacterial Metabolism

Transaldolase (tal) is a key enzyme in the pentose phosphate pathway (PPP), facilitating nucleotide biosynthesis and redox balance. While R. salmoninarum’s genome has not been explicitly analyzed for tal in the provided sources, its metabolic adaptations as an intracellular pathogen suggest reliance on conserved pathways like the PPP.

Recombinant Protein Studies in R. salmoninarum

Although tal-specific studies are absent, methodological frameworks from prior recombinant protein research on R. salmoninarum include:

  • Cloning and Expression: The msa gene (encoding p57) has been expressed recombinantly to study antigenic properties .

  • Structural Modeling: Homology modeling of 412 R. salmoninarum proteins identified 143 reliable 3D structures, submitted to the PMDB database .

Potential Applications of Recombinant Transaldolase

Hypothetical applications based on analogous studies:

  • Diagnostics: Recombinant tal could serve as an antigen for antibody-based detection assays, similar to p57-based ELISAs .

  • Vaccine Development: Immunogenic epitopes of tal might be engineered for subunit vaccines, mirroring approaches tested with p57 .

  • Drug Targeting: Structural insights from homology models could enable inhibitor screening, as demonstrated for DHFR .

Research Gaps and Future Directions

Key gaps identified in the literature:

  • No direct studies on tal’s role in R. salmoninarum virulence or metabolism.

  • Limited structural or functional data on PPP enzymes in this pathogen.

  • Computational modeling (e.g., SwissModel, AutoDock Vina) remains underutilized for tal analysis .

Methodological Recommendations

For future studies on recombinant tal:

  1. Gene Identification: Extract tal sequences from R. salmoninarum genomes (e.g., NCBI BioProject PRJNA258116) .

  2. Cloning: Use vectors like pET-28a for expression in E. coli hosts .

  3. Structural Analysis: Apply homology modeling and Ramachandran plot validation .

  4. Functional Assays: Measure enzyme kinetics and inhibition profiles in vitro.

Product Specs

Form
Lyophilized powder. We will ship the available format. If you have specific format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult local distributors for specific delivery times. Proteins are shipped with blue ice packs by default. Request dry ice in advance (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Working aliquots are stable at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us and we will prioritize its development.
Synonyms
tal; RSal33209_2247; Transaldolase; EC 2.2.1.2
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-374
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Renibacterium salmoninarum (strain ATCC 33209 / DSM 20767 / JCM 11484 / NBRC 15589 / NCIMB 2235)
Target Names
tal
Target Protein Sequence
MTTNTSELSA AGVSIWLDDL SRERLTSGSL QKLIDEKNVV GVTTNPSIFQ AAISKGTSYE QQVSELAAQG ADVEAAVFQI TTQDVANACD FFAGIAVASK GVDGRVSIEV DPRKAWDTQG TIEEAKRLHA AVGKDNVHIK IPATLEGLEA ITETLGAGIS VNVTLIFSLG RYRAVINAFL LGIEKAKANG HDLSQIHSVA SFFVSRVDTE IDKRLDALNT DEAKSLKGKA GVANARLAYQ VFEEVFSSER WALLAEAGAL PQRPLWASTG VKDPAYPDTL YVTELVAPNV VNTMPEKTLD ATADHGVVSG NTISGRYDEA NGVLNALEGL GISYNEVVAL LEKEGLEKFV ASWKELLDHV QDALNSAATK GSES
Uniprot No.

Target Background

Function
Transaldolase maintains metabolic balance in the pentose-phosphate pathway.
Database Links
Protein Families
Transaldolase family, Type 2 subfamily
Subcellular Location
Cytoplasm.

Q&A

What is R. salmoninarum Transaldolase and what is its role in bacterial metabolism?

Transaldolase (tal) is an enzyme involved in the pentose phosphate pathway (PPP), a critical metabolic pathway that generates NADPH and pentoses for nucleotide synthesis. In R. salmoninarum, this enzyme likely plays a crucial role in the bacterium's metabolism during infection of fish hosts. The enzyme catalyzes the reversible transfer of a three-carbon ketol unit from sedoheptulose 7-phosphate to glyceraldehyde 3-phosphate, forming fructose 6-phosphate and erythrose 4-phosphate.

Based on studies of transaldolase in other organisms, the enzyme contributes to:

  • Generation of reducing power (NADPH) for biosynthetic reactions and countering oxidative stress

  • Production of pentoses for nucleic acid synthesis

  • Carbon skeleton rearrangement for metabolic flexibility

In pathogens like R. salmoninarum, the pentose phosphate pathway may be particularly important during infection when the bacterium faces oxidative stress from host immune responses . Transcriptomic studies have shown that R. salmoninarum infection induces complex changes in host immune signaling, suggesting that metabolic enzymes like transaldolase may indirectly influence host-pathogen interactions by supporting bacterial survival and replication.

What expression systems are most suitable for producing recombinant R. salmoninarum transaldolase?

The choice of expression system for R. salmoninarum transaldolase should consider both protein yield and functional integrity. Based on approaches used for similar enzymes, the following systems and considerations are recommended:

  • E. coli-based expression systems:

    • BL21(DE3) strains with pET vector systems offer high-level expression under T7 promoter control

    • Addition of fusion tags (His6, GST, or MBP) facilitates purification and may enhance solubility

    • Codon optimization may be necessary due to potential codon usage differences between R. salmoninarum and E. coli

  • Expression conditions optimization:

    • Lower induction temperatures (16-20°C) often increase soluble protein yield for enzymes

    • IPTG concentration typically between 0.1-0.5 mM

    • Harvesting cells at optimal time points (4-16 hours post-induction) based on activity assays

  • Alternative expression hosts:

    • Gram-positive expression hosts like Bacillus subtilis might provide advantages for R. salmoninarum proteins

    • Cold-adapted expression systems could be beneficial given R. salmoninarum's growth in cold-water fish

For the E. coli transaldolase B, expression levels of 4 U/mg were achieved in recombinant strains compared to 0.1 U/mg in wild-type cells, demonstrating the potential for significant yield improvement through recombinant approaches . A similar optimization strategy could be applied for R. salmoninarum transaldolase.

What purification strategy would yield highly pure and active R. salmoninarum transaldolase?

A multi-step purification strategy based on approaches used for other bacterial transaldolases would likely be effective:

  • Initial preparation:

    • Cell lysis using sonication or high-pressure homogenization in buffer containing protease inhibitors

    • Clarification by centrifugation (15,000-20,000 × g, 30-45 minutes)

  • Ammonium sulfate fractionation:

    • Sequential precipitation steps (e.g., 0-55% and 55-70% saturation) can provide initial enrichment

    • The precipitate containing enzyme activity should be dissolved and desalted via dialysis or gel filtration

  • Chromatographic purification sequence:

    • Ion exchange chromatography: Q-Sepharose or DEAE columns with NaCl gradient (100-150 mM)

    • Affinity chromatography: If expressed with His-tag, immobilized metal affinity chromatography

    • Gel filtration: Final polishing step to remove aggregates and achieve buffer exchange

  • Quality assessment:

    • SDS-PAGE for purity evaluation

    • Activity assays to confirm functional integrity

    • Mass spectrometry for identity confirmation

The E. coli transaldolase B was successfully purified to homogeneity using two rounds of ammonium sulfate precipitation followed by anion-exchange chromatography, yielding approximately 130 mg of purified enzyme from a 10-liter culture with 50% recovery of initial activity . This provides a practical benchmark for R. salmoninarum transaldolase purification efforts.

Purification StepTypical Yield (%)Fold PurificationChallenges
Crude extract1001High protein content, proteases
Ammonium sulfate75-852-3Salt removal required
Ion exchange60-7010-15Optimizing elution conditions
Affinity (if tagged)50-6020-30Tag interference with activity
Gel filtration40-5025-35Dilution of sample

What assays can be used to measure R. salmoninarum transaldolase activity?

Several complementary assay methods can be employed to characterize R. salmoninarum transaldolase activity:

  • Spectrophotometric coupled enzyme assays:

    • Standard approach linking transaldolase reaction to NAD(P)H-dependent enzymes

    • Typical assay components include:

      • Fructose 6-phosphate and erythrose 4-phosphate as substrates

      • Auxiliary enzymes: triosephosphate isomerase, glycerol-3-phosphate dehydrogenase

      • NAD(P)H monitored at 340 nm

    • Advantages include continuous monitoring and equipment accessibility

  • Direct product analysis methods:

    • HPLC or LC-MS for quantification of substrates and products

    • Separation parameters: Aminex HPX-87H column or similar ion-exchange columns

    • Detection: Refractive index or mass spectrometry

    • Provides direct measurement without interference from coupling enzymes

  • Inhibition studies:

    • Competitive inhibitors like arabinose 5-phosphate at concentrations of 100 μM to 10 mM can be used to characterize active site properties

    • Inhibition patterns provide insights into binding mechanisms and substrate specificity

  • Kinetic parameter determination:

    • Measuring initial reaction rates at varying substrate concentrations

    • Calculating Km, Vmax, kcat, and catalytic efficiency (kcat/Km)

    • Comparative kinetics with different substrates to determine substrate preference

For E. coli transaldolase B, inhibition studies with arabinose 5-phosphate and L-glyceraldehyde showed competitive inhibition patterns that provided insights into the enzyme's substrate binding properties . Similar approaches could reveal unique characteristics of R. salmoninarum transaldolase.

How might R. salmoninarum transaldolase contribute to the pathogen's survival during infection?

Transaldolase likely plays several important roles in R. salmoninarum pathogenesis:

Understanding these contributions could provide insights into R. salmoninarum pathogenesis and reveal potential targets for intervention strategies.

How can recombinant R. salmoninarum transaldolase be used in developing improved diagnostic methods for BKD?

Recombinant R. salmoninarum transaldolase offers several potential applications for BKD diagnostics:

  • Serological diagnostics:

    • Development of specific antibodies against purified recombinant transaldolase

    • Implementation in ELISA, lateral flow immunochromatographic assays, or immunohistochemistry

    • Potential for detecting subclinical infections where bacterial load may be low

  • Molecular detection approaches:

    • PCR primers targeting the tal gene for conventional or quantitative PCR

    • Isothermal amplification methods similar to those developed for other R. salmoninarum targets

    • Integration into multiplex PCR assays targeting multiple R. salmoninarum genes simultaneously

  • Environmental monitoring:

    • Water sampling and molecular detection for early warning in aquaculture facilities

    • R. salmoninarum can survive in seawater long enough for horizontal transmission , making environmental monitoring valuable

    • Early detection could enable preventive measures before clinical disease appears

  • Advantages over current methods:

    • Current detection methods for R. salmoninarum include culture (slow and labor-intensive), ELISA (variable sensitivity), and PCR

    • Transaldolase-based methods could potentially offer improved sensitivity or specificity

    • Isothermal amplification methods may enable relatively rapid detection compared to culture methods and conventional PCR

Early detection of R. salmoninarum is crucial for aquaculture management to enable rapid treatment with targeted antibiotics and prevent BKD outbreaks in hatcheries and aquaculture stocks .

What approaches can be used to investigate R. salmoninarum transaldolase's role in bacterial pathogenesis?

Multiple complementary approaches can elucidate transaldolase's role in R. salmoninarum pathogenesis:

  • Transcriptomic and proteomic analyses:

    • RNA-seq to determine tal expression patterns during different infection stages

    • Quantitative proteomics to measure enzyme abundance in various conditions

    • Comparison between virulent and attenuated strains to correlate expression with pathogenicity

  • Gene knockout/knockdown studies:

    • Construction of tal mutants (if genetic tools are available for R. salmoninarum)

    • Conditional expression systems to regulate tal expression

    • Assessment of mutant phenotypes in vitro and in fish infection models

  • Enzyme inhibition studies:

    • Application of transaldolase inhibitors to bacterial cultures

    • Evaluation of growth, survival, and virulence factor expression

    • Testing inhibitor effects on bacterial survival in fish cell lines

  • Host-pathogen interaction models:

    • Infection of fish cell lines or primary kidney cells with R. salmoninarum

    • Monitoring transaldolase activity during intracellular growth

    • Correlation with changes in host cell signaling and metabolism

  • In vivo infection studies:

    • Experimental infection of fish with wild-type and tal-modified strains

    • Assessment of bacterial load, tissue distribution, and disease progression

    • Correlation of transaldolase activity with bacterial persistence

Transcriptomic studies have already provided insights into how R. salmoninarum infection dysregulates diverse immune mechanisms in lumpfish . Similar approaches focusing specifically on transaldolase could reveal its contributions to these processes.

What structural biology techniques can be applied to characterize R. salmoninarum transaldolase structure-function relationships?

Several complementary structural biology approaches can illuminate R. salmoninarum transaldolase structure-function relationships:

A combination of these approaches would provide comprehensive insights into the enzyme's catalytic mechanism, substrate specificity, and potential for inhibitor development.

How can computational methods advance understanding of R. salmoninarum transaldolase and facilitate inhibitor design?

Computational approaches offer powerful tools for studying R. salmoninarum transaldolase:

  • Homology modeling and structure prediction:

    • Using solved structures of related transaldolases (e.g., E. coli talB ) as templates

    • AI-based structure prediction (AlphaFold2, RoseTTAFold) for model generation

    • Refinement through molecular dynamics to predict dynamic behavior

  • Virtual screening and docking:

    • In silico screening of compound libraries against predicted binding sites

    • Molecular docking to evaluate potential inhibitor binding modes and affinities

    • Fragment-based approaches to identify building blocks for inhibitor design

  • Molecular dynamics simulations:

    • Investigating protein dynamics under conditions mimicking the bacterial environment

    • Analyzing conformational changes upon substrate or inhibitor binding

    • Predicting effects of temperature, pH, and ionic strength on enzyme stability

  • Quantum mechanics/molecular mechanics (QM/MM):

    • Detailed modeling of reaction mechanisms and transition states

    • Calculating energetic barriers for catalysis

    • Understanding electronic properties relevant to inhibitor design

  • Systems biology approaches:

    • Metabolic modeling to predict consequences of transaldolase inhibition

    • Network analysis to identify potential compensatory pathways

    • Integration with transcriptomic data to understand the enzyme's role during infection

  • Machine learning applications:

    • Developing QSAR models for inhibitor property prediction

    • Pattern recognition in protein-ligand interactions

    • Utilizing techniques similar to those developed for contradiction detection in data analysis

Computational methods can accelerate experimental research by prioritizing promising experimental directions and providing mechanistic insights that may be difficult to obtain experimentally.

How can contradictions in experimental data about R. salmoninarum transaldolase be systematically addressed?

Scientific investigation often produces seemingly contradictory results. A systematic approach to resolving contradictions in R. salmoninarum transaldolase research includes:

  • Methodological standardization:

    • Establishing consistent protocols for enzyme preparation and characterization

    • Defining standard assay conditions (temperature, pH, buffer composition)

    • Creating reference materials to enable cross-laboratory comparisons

  • Statistical analysis approaches:

    • Meta-analysis of data from multiple studies to identify patterns and outliers

    • Uncertainty quantification to determine if contradictions fall within expected error ranges

    • Sensitivity analysis to identify parameters most affecting experimental outcomes

  • Biological variability assessment:

    • Comparing transaldolase from different R. salmoninarum strains/isolates

    • Investigating the influence of bacterial growth conditions on enzyme properties

    • Examining potential post-translational modifications affecting enzyme function

  • Multi-technique verification:

    • Applying complementary analytical methods to the same samples

    • Using orthogonal approaches to validate key findings

    • Combining in vitro, in silico, and in vivo methods for comprehensive understanding

  • Collaborative verification studies:

    • Multi-laboratory studies using standardized protocols

    • Blind sample testing to minimize confirmation bias

    • Open data sharing to enable independent analysis

  • Linguistic and analytical contradiction resolution:

    • Applying linguistic rules and machine learning approaches for identifying contradictions in research literature

    • Distinguishing between genuine contradictions and contextual differences

    • Reconciling contradictory findings through expanded theoretical frameworks

These approaches can help build a coherent understanding of R. salmoninarum transaldolase despite the experimental challenges associated with this fastidious fish pathogen.

What criteria should be considered when evaluating R. salmoninarum transaldolase as a potential drug target?

Evaluating transaldolase as a therapeutic target requires consideration of several key criteria:

  • Essentiality assessment:

    • Determining whether transaldolase activity is essential for R. salmoninarum survival

    • Evaluating if alternative metabolic pathways can compensate for transaldolase inhibition

    • Assessing the impact of reduced transaldolase activity on bacterial virulence

  • Structural uniqueness:

    • Comparing R. salmoninarum transaldolase with host (fish) enzymes

    • Identifying bacterial-specific structural features amenable to selective targeting

    • Determining if sufficient selectivity can be achieved to avoid host toxicity

  • Druggability evaluation:

    • Assessing active site and allosteric site properties for small molecule binding

    • Evaluating solvent accessibility of potential binding pockets

    • Determining if the enzyme has exploitable conformational states

  • Validation strategies:

    • Genetic approaches (gene knockdown/knockout) to establish target validity

    • Chemical biology methods using tool compounds to probe enzyme function

    • In vivo studies correlating enzyme inhibition with reduced bacterial load

  • Aquaculture application considerations:

    • Delivery methods compatible with fish farming (feed incorporation, water treatment)

    • Environmental impact assessment of potential inhibitors

    • Economic feasibility analysis compared to current treatment options

Early detection of R. salmoninarum is important for treatment with targeted antibiotics to prevent BKD outbreaks , but novel approaches targeting essential bacterial enzymes could provide additional tools for disease management in aquaculture.

What are the potential challenges in developing vaccines based on R. salmoninarum transaldolase?

Vaccine development using R. salmoninarum transaldolase faces several specific challenges:

  • Immune response considerations:

    • R. salmoninarum causes immune suppression at early infection stages

    • The bacterium induces cell-mediated immune responses during chronic infection

    • Vaccine design must overcome the pathogen's immunosuppressive capabilities

  • Antigen properties evaluation:

    • Determining if transaldolase is sufficiently immunogenic in fish

    • Assessing whether antibodies against transaldolase would be protective

    • Identifying immunodominant epitopes that could be incorporated into subunit vaccines

  • Delivery system development:

    • Injection: Most reliable but labor-intensive and stressful for fish

    • Immersion: More practical but typically induces weaker immunity

    • Oral delivery: Most scalable but faces challenges with antigen degradation

  • Adjuvant selection:

    • Identifying adjuvants compatible with fish immune systems

    • Balancing immunostimulation with practical administration methods

    • Ensuring adjuvant safety for fish and environmental compatibility

  • Efficacy assessment:

    • Developing challenge models that accurately reflect natural infection

    • Establishing correlates of protection in fish

    • Determining duration of immunity under aquaculture conditions

  • Production challenges:

    • Scaling recombinant protein production for commercial application

    • Ensuring consistent protein quality and stability

    • Developing cost-effective manufacturing processes

Given that R. salmoninarum can be transmitted through fecal-oral routes and survive in water , effective vaccination strategies could significantly reduce disease transmission in aquaculture settings if these challenges can be overcome.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.